Literature DB >> 22398673

Cholesterol and triglyceride concentrations in lipoproteins as related to carotid intima-media thickness.

Ryotaro Takahashi1, Noriko Taguchi, Masayuki Suzuki, Xian Wu Cheng, Yasushi Numaguchi, Hideto Tsukamoto, Nobuo Ikeda, Toyoaki Murohara, Kenji Okumura.   

Abstract

Since distinct cholesterol and triglyceride concentrations in major lipoproteins and their subclasses may be related to atherosclerosis, we investigated the relationship of cholesterol and triglyceride concentrations in lipoprotein subclasses and the severity of carotid intima-media thickness (IMT), a surrogate marker of subclinical atherosclerosis. We studied 116 apparently healthy Japanese men (53 ± 9 years) without a history of cardiovascular diseases who were not taking any medication. Carotid IMT was measured by means of high-resolution vascular ultrasound. Plasma cholesterol and triglyceride concentrations in major lipoproteins and their subclasses were determined by HPLC with gel permeation columns. By univariate analyses, carotid IMT was the most closely related to age (r = 0.528, P < 0.001), followed by smoking habit expressed as pack-year cigarette consumption (r = 0.409, P < 0.001). In addition to total cholesterol and LDL cholesterol, carotid IMT was significantly associated with cholesterol and triglyceride concentrations in several LDL and VLDL subclasses. Stepwise multiple linear regression analysis revealed that age (β = 0.436, P < 0.001), smoking (pack-years) (β = 0.225, P = 0.007), and large LDL cholesterol (β = 0.175, P = 0.023) were independent predictors of determining carotid IMT (adjusted R(2) = 0.347, P < 0.001). These results indicate that large LDL cholesterol is an important, independent determinant of carotid IMT in healthy men.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22398673     DOI: 10.1536/ihj.53.29

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  7 in total

1.  High HDL cholesterol level after treatment with pitavastatin is an important factor for regression in carotid intima-media thickness.

Authors:  Kenji Okumura; Hideto Tsukamoto; Hideyuki Tsuboi; Haruo Hirayama; Haruo Kamiya; Masato Watarai; Ryoji Ishiki; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2014-01-24       Impact factor: 2.037

2.  Association between the MARS rs6782181 polymorphism and serum lipid levels.

Authors:  Jian Wu; Rui-Xing Yin; Tao Guo; Quan-Zhen Lin; Guang-Yuan Shi; Jia-Qi Sun; Shao-Wen Shen; Yi-Ming Wang; Hui Li; Jin-Zhen Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

3.  Two-hour postload glycemia is associated to an increased risk of NAFLD in healthy subjects with family history of type 2 diabetes: a case control study.

Authors:  Nadia Pallotta; Tiziana Filardi; Anna Carnovale; Luciano Nieddu; Paola Mariani; Giuseppina Vincoli; Andrea Lenzi; Susanna Morano
Journal:  Endocrine       Date:  2016-07-15       Impact factor: 3.633

4.  Decision tree analysis of traditional risk factors of carotid atherosclerosis and a cutpoint-based prevention strategy.

Authors:  Guangming Qin; Laisheng Luo; Lihong Lv; Yufei Xiao; Jiangfeng Tu; Lisha Tao; Jiaqi Wu; Xiaoxiao Tang; Wensheng Pan
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

5.  Roles of triglyceride and phosphate in atherosclerosis of diabetic hemodialysis patients.

Authors:  Mohammad Rezapour; Elnaz Payani; Masoumeh Taran; Ali Rajabzadeh Ghatari; Morteza Khavanin Zadeh
Journal:  Med J Islam Repub Iran       Date:  2017-12-15

6.  The influence of MRAS gene variants on ischemic stroke and serum lipid levels in Chinese Han population.

Authors:  Yan Song; Rui Ma; Hongjuan Zhang
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

7.  Body Mass Index and 1-Year Unplanned Readmission in Chinese Patients with Acute Myocardial Infarction: A Retrospective Cohort Study.

Authors:  Dandan Sun; Qingyun Zhang; Wei Li; Haichen Wang
Journal:  Cardiol Res Pract       Date:  2020-02-18       Impact factor: 1.866

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.